Hormone-dependent prostate cancer is a type of prostate cancer that relies on male sex hormones, particularly testosterone, to grow and spread. Understanding this condition and how hormones fuel cancer cells is essential for patients and their families as they navigate treatment options and learn to manage the changes that come with therapy.
Understanding Hormone-Dependent Prostate Cancer
Prostate cancer is one of the most frequently diagnosed cancers in men worldwide. Among women and men, hormone-dependent cancers of the breast and prostate are the most common, respectively. The prostate is a small gland that sits below the bladder and plays a role in making semen, which is part of the male reproductive system. When cancer develops in this gland, it often depends on hormones to continue growing.[1][3]
The term “hormone-dependent” means that the cancer cells need male sex hormones, called androgens, to survive and multiply. The most important androgens in men are testosterone and a related hormone called dihydrotestosterone, or DHT. Almost all of the testosterone in a man’s body is made in the testicles, with a small amount produced by the adrenal glands. These hormones travel through the bloodstream and reach prostate cells, where they attach to a protein called the androgen receptor. When this happens, the receptor becomes activated and tells the cell to grow. This process occurs in both healthy prostate cells and cancerous ones.[1]
Early in their development, most prostate cancers require androgens to grow. This is why they are described as hormone-dependent, hormone-sensitive, androgen-dependent, or castration-sensitive. These terms all refer to the same idea: the cancer’s growth can be slowed or stopped by reducing the levels of testosterone in the body or by blocking testosterone from reaching cancer cells. Doctors use this knowledge to design treatments that target the hormones feeding the cancer.[1][6]
Epidemiology and Patterns
Prostate cancer remains the second leading cause of cancer-related deaths among men in North America. It is the most commonly diagnosed cancer in men across many parts of the world. Hormone-dependent cancers of the breast and prostate account for a significant portion of new cancer diagnoses each year, with hormone-receptor-positive breast cancers accounting for around seventy-five percent of new breast cancer diagnoses in women, and prostate cancer following a similar pattern in men.[3][5]
The disease affects men at different stages of life, but it is more commonly diagnosed in older men. Age is one of the strongest risk factors, with the likelihood of developing prostate cancer increasing significantly after the age of fifty. The patterns of diagnosis and survival have changed over the years as screening methods have improved and treatments have become more advanced. However, the fundamental role of hormones in driving the growth of most prostate cancers has remained a constant feature of the disease.[5]
Causes of Hormone-Dependent Prostate Cancer
The exact cause of prostate cancer is not fully understood, but researchers know that certain factors play a role in its development. At the most basic level, prostate cancer begins when cells in the prostate gland start to grow uncontrollably. These abnormal cells form a tumor that can invade nearby tissues or spread to other parts of the body. What makes these cancers hormone-dependent is their reliance on androgens to fuel their growth.[1]
Androgens are essential for the normal growth and function of the prostate. They help maintain male characteristics and support reproductive health. However, when cancer develops, these same hormones become a problem because they promote the growth of both normal and cancerous prostate cells. The cancer cells have androgen receptors on their surface, and when testosterone or DHT binds to these receptors, it triggers a series of signals inside the cell that tell it to grow and divide.[1]
Although prostate cells do not normally produce testosterone, some prostate cancer cells can develop the ability to make their own supply of testosterone. This adaptation is one reason why some cancers eventually become resistant to hormone therapy. The cancer cells essentially create their own fuel source, allowing them to continue growing even when testosterone from the testicles and adrenal glands has been blocked.[1]
Risk Factors
Several factors can increase a man’s risk of developing hormone-dependent prostate cancer. Age is the most significant risk factor, with the vast majority of cases occurring in men over the age of sixty-five. The risk increases steadily as men get older, which is why regular screening is often recommended for men in their fifties and beyond.[5]
Family history also plays an important role. Men who have a father, brother, or other close male relative with prostate cancer are at higher risk of developing the disease themselves. This suggests that genetic factors may contribute to the development of hormone-dependent prostate cancer. Certain inherited genetic mutations can increase susceptibility, although most cases occur in men without a strong family history.[3]
Race and ethnicity are additional risk factors. Black men have a higher incidence of prostate cancer compared to men of other racial and ethnic groups, and they are also more likely to be diagnosed at a younger age and with more aggressive forms of the disease. The reasons for these disparities are complex and may involve a combination of genetic, environmental, and socioeconomic factors.[3]
Diet and lifestyle may also influence risk, although the evidence is not as clear-cut. Some studies have suggested that high dietary cholesterol intake and certain dietary patterns may be associated with an increased risk of prostate cancer. Obesity and lack of physical activity have also been linked to higher risk and worse outcomes. However, more research is needed to fully understand how these factors contribute to the development of hormone-dependent prostate cancer.[3]
Symptoms of Hormone-Dependent Prostate Cancer
In its early stages, hormone-dependent prostate cancer often does not cause any noticeable symptoms. Many men are diagnosed through routine screening tests, such as a blood test that measures prostate-specific antigen, or PSA, before they experience any problems. This is one reason why screening is so important—it can detect cancer before symptoms appear, when treatment is most likely to be effective.[1]
When symptoms do occur, they are often related to changes in urinary function. The prostate surrounds part of the urethra, which is the tube that carries urine out of the body. As a tumor grows, it can press on the urethra and cause problems such as difficulty starting urination, a weak or interrupted urine stream, frequent urination (especially at night), or a feeling that the bladder has not completely emptied. These symptoms can also be caused by non-cancerous conditions like an enlarged prostate, so it is important to see a doctor for proper evaluation.[1]
In more advanced cases, when the cancer has spread beyond the prostate, symptoms may include pain in the bones, back, hips, or pelvis, blood in the urine or semen, unexplained weight loss, or fatigue. These symptoms indicate that the cancer may have reached other parts of the body and require prompt medical attention.[1]
Prevention Strategies
There is no guaranteed way to prevent hormone-dependent prostate cancer, but certain steps may help reduce risk or detect the disease at an earlier, more treatable stage. Regular screening is one of the most important preventive measures for men at higher risk. Screening typically involves a PSA blood test and sometimes a digital rectal exam, where a doctor checks the prostate for any abnormalities. Men should discuss with their healthcare provider when to start screening and how often to have it done, based on their age, family history, and other risk factors.[1]
Maintaining a healthy lifestyle may also play a role in prevention. Eating a balanced diet rich in fruits, vegetables, and whole grains, while limiting red meat and high-fat foods, may help lower risk. Regular physical activity and maintaining a healthy weight are also beneficial. Some research suggests that certain nutrients, such as vitamin D and lycopene (found in tomatoes), may have protective effects, but more studies are needed to confirm these findings.[3]
For men with a strong family history of prostate cancer or known genetic mutations, genetic counseling may be helpful. This can provide information about risk and guide decisions about screening and prevention strategies. Although hormone-dependent prostate cancer cannot always be prevented, early detection through screening offers the best chance for successful treatment and improved outcomes.[3]
Pathophysiology: How the Disease Changes the Body
Understanding the pathophysiology of hormone-dependent prostate cancer means looking at how the disease affects normal body functions at a mechanical, physical, and biochemical level. In a healthy prostate, androgens like testosterone play a vital role in maintaining the gland’s size, function, and ability to produce fluid for semen. Testosterone is regulated by a complex system involving the brain and testicles. The hypothalamus in the brain releases a hormone called luteinizing hormone-releasing hormone, or LHRH, which signals the pituitary gland to release luteinizing hormone, or LH. LH then tells the testicles to produce testosterone.[1]
Once testosterone is produced, it travels through the bloodstream to the prostate, where it either binds directly to androgen receptors on prostate cells or is converted into DHT, which has an even stronger ability to bind to these receptors. When the androgen receptor is activated, it moves into the cell’s nucleus and stimulates the expression of specific genes that cause the cell to grow and divide. This process is normal and necessary for the prostate to function properly.[1]
In hormone-dependent prostate cancer, this normal process goes awry. Cancer cells have the same androgen receptors as normal cells, and they respond to testosterone and DHT in the same way—by growing and dividing. The difference is that cancer cells grow uncontrollably, forming a tumor that can invade surrounding tissues and potentially spread to other parts of the body, such as the bones, lymph nodes, or other organs. This spread, called metastasis, is what makes prostate cancer life-threatening.[1][5]
Over time, some prostate cancer cells undergo changes that allow them to survive and grow even when androgen levels are very low. These changes can include amplification of the androgen receptor gene, meaning the cells make more copies of the receptor and become more sensitive to even tiny amounts of androgens. Other cancer cells develop mutations in the androgen receptor that change its shape, allowing it to be activated by other hormones or even by no hormone at all. Some cancer cells learn to produce their own testosterone, bypassing the need for testosterone from the testicles or adrenal glands. Still others activate alternative pathways that allow them to grow without relying on androgens at all. These adaptations are why most prostate cancers eventually become castration-resistant, meaning they no longer respond to treatments that lower testosterone levels.[1][5]
Hormone-dependent prostate cancer also has effects beyond the prostate itself. When the cancer spreads to the bones, it can cause pain, fractures, and other complications. Bone is a common site of metastasis for prostate cancer, and the presence of cancer in the bones can disrupt normal bone turnover, leading to weakening of the bone structure. The cancer can also affect other organs and systems, depending on where it spreads, leading to a wide range of symptoms and complications.[5]
The body’s response to hormone-dependent prostate cancer and its treatment can also cause changes. When men undergo hormone therapy to lower testosterone levels, they experience a range of side effects related to low androgen levels. These can include hot flushes, loss of muscle mass and strength, weight gain, bone thinning, fatigue, changes in mood and thinking, and sexual dysfunction. These side effects reflect the important role that testosterone plays throughout the body, not just in the prostate.[2][15]
